Skip to main content

Table 1 Fatty acid composition of total serum lipids from patients with polymyositis and dermatomyositis compared to healthy individuals

From: Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis

FA Healthy individuals,weight % Patients,weight %
C14:0 1.6 ± 0.8 2.1 ± 0.7
C16:0 21.6 ± 5.2 24.5 ± 3.0*
C16:1 1.8 ± 0.7 2.1 ± 0.8
C18:0 9.8 ± 1.0 8.9 ± 1.3
C18:1 24.7 ± 3.0 26.5 ± 4.6
C18:2(n-6) 27.9 ± 4.4 25.6 ± 5.1
C18:3(n-3) 1.4 ± 0.7 1.2 ± 0.5
C20:3(n-6) 1.3 ± 0.4 1.1 ± 0.5
C20:4(n-6) 5.4 ± 1.1 4.3 ± 1.3*
C20:5(n-3) 2.2 ± 1.2 1.8 ± 1.4
C22:6(n-3) 2.4 ± 0.8 1.9 ± 0.7
SFA 32.9 ± 4.9 35.5 ± 3.0
MUFA 26.5 ± 3.4 28.7 ± 5.1
PUFA 40.5 ± 5.8 35.8 ± 7.3
n-3 PUFA 5.9 ± 1.7 4.9 ± 2.0
n-6 PUFA 34.6 ± 4.9 30.9 ± 6.3
  1. Values given as mean ± SD
  2. FA fatty acids, SFA saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids
  3. *p < 0.05 for patients versus healthy individuals